Finance News Network Episodes
17 Oct 2018 - The ASX is still trading higher this morning, as major banks saw rises - Commonwealth Bank was leading the way. Australian pot stocks are soaring as Canada is legalising recreational cannabis today. Bellamy's Australia is up as is Bl...
17 Oct 2018 - Tabcorp (ASX:TAH) reported a statutory profit after tax of $28.7 million, impacted by significant items after tax of $217 million, principally associated with the Tatts combination, Sun Bets exit and Luxbet closure.
17 Oct 2018 - Building company Boral (ASX:BLD) today announced that it has agreed to sell its US Block business to Quikrete Holdings, Inc. for US$156 million.
17 Oct 2018 - Woodfibre company Midway (ASX:MWY) closed the offer period of its share purchase plan announced on Friday, 12 October 2018, raising approximately $3.15 million.
17 Oct 2018 - Highlands Pacific (ASX:HIG) has appointed Ernie Gangloff as a Non-Executive Director, replacing Bart Philemon, who has retired from the Board.
17 Oct 2018 - BHP (ASX:BHP) saw its first quarter iron ore production rise eight per cent on the prior corresponding period.
17 Oct 2018 - BlueScope Steel (ASX:BSL) today announced that its wholly owned subsidiary New Zealand Steel has acquired approximately 15.8 per cent of the shares in Steel & Tube Holdings.
17 Oct 2018 - The climb continues as Australian shares are set to see a rise this morning after a rally in Europe and Wall Street overnight. Technology stocks extended. Stocks in Hong Kong rose after a few days of losses. 1300SMILES (ASX:ONT) has ...
17 Oct 2018 - Oventus Medical Limited (ASX:OVN) founder, Managing Director and CEO, Dr Chris Hart discusses the company's sales push into the US, new product development and changes in the treatment of sleep apnoea.
16 Oct 2018 - Market at Midday. Clawing back from yesterday's 1% slide with miners leading rally after lead & gold muster up. Cannabis stocks rally, AusCann (ASX:AC8) 3% higher ahead of Canada's legalisation decision. Propertylink Group (ASX:PLG) ...
16 Oct 2018 - Race Oncology (ASX:RAC) CEO, Peter Molloy talks about its Investigational New Drug (IND) Application with the U.S. FDA for its leukemia drug candidate Bisantrene.